Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 2005

View Archived Issues

Good efficacy reported for anidulafungin in invasive candidiasis

New phase III data on the efficacy of RSD-1235 in atrial arrhythmia

Excellent preclinical data on rilpivirine, an anti-HIV agent from Janssen

Preclinical data affirms anticancer properties of adecatumumab

Therapeutic potential of AZD-7009 for common tachyarrhythmias

In vivo imaging efficacy of EP-2104R in detecting carotid artery thrombi in rabbits

Synthesis and preclinical efficacy of a peripherally selective COMT inhibitor BIA-3-335

Delay to Preos NDA submission

Arexis receives EU orphan drug status for BSSL for the treatment of cystic fibrosis

U. of Pittsburgh to support development of NK cell therapy for cancer

Full approval for Doxil

PDUFA dates set for Cesamet filing

Diosynth and Pharming sign manufacturing agreement for rhC1INH

AustCancer establishes U.S. office, proposes name change

MethylGene and EnVivo enter into HDAC collaboration agreement

Phase III trial of SU-11248 for GIST demonstrates early efficacy

Arixtra receives new approval in Europe

FDA raises questions over Probactrix IND

Zydus Cadila files IND in India for ZY-H1

Beyond Genomics changes name to BG Medicine

Speedel reports promising results for its new renin inhibitors SPP-630 and SPP-635 / News in Context

Valproate reported to reduce heavy drinking in patients with bipolar disorder

Evidence suggests gabapentin may be effective for cancer-induced bone pain

Add-on selegiline therapy improves negative symptoms in schizophrenia

New agents for the treatment of pain in early development at Vertex

Novel anti-HIV agents developed by Lead Chemical researchers

Japan Tobacco discloses calcium-sensing receptor antagonists for osteoporosis

New triterpenoid compound for cancer reported by Sumitomo

Antitumoral discorhabdin compounds imparted by the Harbor Branch Oceanographic Institution

Dainippon claims new inducible nitric oxide synthase inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...